Opaleye Management as of March 31, 2014
Portfolio Holdings for Opaleye Management
Opaleye Management holds 30 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Retrophin | 18.1 | $24M | 1.2M | 21.20 | |
| Ariad Pharmaceuticals | 9.9 | $14M | 1.7M | 8.06 | |
| Chimerix (CMRX) | 9.0 | $12M | 536k | 22.84 | |
| Pharmacyclics | 8.5 | $12M | 115k | 100.22 | |
| Inspiremd | 4.8 | $6.6M | 2.2M | 3.05 | |
| Omeros Corporation (OMER) | 4.5 | $6.0M | 500k | 12.07 | |
| Cempra | 4.1 | $5.5M | 480k | 11.55 | |
| Bind Therapeutics | 3.8 | $5.1M | 427k | 11.96 | |
| NPS Pharmaceuticals | 3.3 | $4.5M | 150k | 29.93 | |
| GenMark Diagnostics | 3.2 | $4.3M | 435k | 9.94 | |
| Cardiovascular Systems | 3.2 | $4.3M | 135k | 31.79 | |
| Novadaq Technologies | 3.0 | $4.1M | 168k | 24.56 | |
| D Fluidigm Corp Del (LAB) | 2.9 | $4.0M | 90k | 44.07 | |
| Biolinerx Ltd-spons | 2.4 | $3.2M | 1.5M | 2.23 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.3 | $3.1M | 1.4M | 2.26 | |
| Epizyme | 1.9 | $2.6M | 116k | 22.77 | |
| Ligand Pharmaceuticals In (LGND) | 1.7 | $2.4M | 35k | 67.26 | |
| Geron Corporation (GERN) | 1.7 | $2.3M | 1.1M | 2.09 | |
| Flexion Therapeutics | 1.6 | $2.2M | 136k | 16.45 | |
| Evoke Pharma | 1.4 | $2.0M | 233k | 8.38 | |
| Celgene Corp right 12/31/2011 | 1.4 | $1.9M | 660k | 2.85 | |
| Tetraphase Pharmaceuticals | 1.3 | $1.8M | 160k | 10.98 | |
| Kalobios Pharmaceuticals | 1.1 | $1.5M | 545k | 2.70 | |
| Array BioPharma | 1.1 | $1.4M | 305k | 4.70 | |
| Codexis (CDXS) | 1.1 | $1.4M | 698k | 2.04 | |
| Celator Pharmaceuticals | 0.8 | $1.0M | 325k | 3.17 | |
| Macrogenics (MGNX) | 0.6 | $838k | 30k | 27.93 | |
| Affymetrix | 0.5 | $713k | 100k | 7.13 | |
| Kips Bay Med | 0.4 | $537k | 778k | 0.69 | |
| Sunshine Heart | 0.3 | $350k | 60k | 5.83 |
